Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 25,314	$ 13,760
Short-term investments	44,381	52,243
Research and development tax credits receivable	901	643
Prepaid expenses	1,840	3,178
Other receivables	1,490	3,208
Total current assets	73,926	73,032
Operating lease right-of-use assets	1,376	1,917
Property and equipment	197	277
Total assets	75,499	75,226
Current liabilities
Accounts payable and accrued liabilities	7,555	6,680
Operating lease liabilities	571	546
Total current liabilities	8,126	7,226
Operating lease liabilities, net of current portion	874	1,457
Senior secured convertible notes	53,352	49,772
Total liabilities	62,352	58,455
Shareholders' Equity
Common shares, no par value, unlimited shares authorized 53,269,565 shares issued and outstanding as of June 30, 2024, 33,483,111 shares issued and outstanding as of December 31, 2023	288,048	260,504
Pre-funded warrants - 12,910,590 issued and outstanding as of June 30, 2024 and 9,577,257 as of December 31, 2023	53,076	48,459
Additional paid-in capital	39,568	33,834
Accumulated deficit	(367,545)	(326,026)
Total shareholders' equity	13,147	16,771
Total liabilities and shareholders' equity	$ 75,499	$ 75,226